Could Middle East Tensions Disrupt India’s Pharmaceutical Export Supply Chains?

Escalating tensions in the Middle East are raising concerns for India’s pharmaceutical export sector, which relies on predictable shipping routes and specialised logistics systems. Industry participants indicate that disruptions across key maritime corridors and air routes could slow deliveries to several global markets as per Economic Times report.

Longer transit times, rising freight costs and operational uncertainties may influence supply chains, particularly for medicines that require temperature-controlled transportation and time-sensitive handling.

Dependence on Key Maritime Trade Routes

A substantial portion of India’s pharmaceutical exports bound for Europe, North Africa and parts of the United States travels through the shipping corridor connecting the Red Sea and the Suez Canal.

If shipping companies continue to avoid this route due to regional tensions and instead navigate around the Cape of Good Hope, transit times from India to Europe could increase by around 10 to 15 days. Such delays may affect supply chain planning and inventory management for exporters.

Challenges for Temperature-Sensitive Medicines

Extended transit times present additional challenges for pharmaceutical shipments that require controlled storage conditions.

Products such as biologics, vaccines and certain injectable medicines are particularly sensitive to variations in temperature and handling conditions. The longer a shipment remains in transit, the greater the exposure to logistical risks related to storage stability and shelf-life management.

Importance of the Middle East as a Market

The Middle East itself represents an important destination for Indian generic medicines. Countries such as the United Arab Emirates, Saudi Arabia, and Iraq account for a considerable share of pharmaceutical exports from India.

Industry participants note that heightened tensions could affect port operations, banking channels and local distribution systems in these markets. Such disruptions may lead to delays in shipments, payment processing and product availability.

Rising Freight and Insurance Costs

Logistics expenses are another area of concern for exporters. Pharmaceutical shipments often consist of high-value goods transported in relatively smaller volumes, which means transportation costs can influence overall margins.

War-risk insurance premiums and higher container freight rates in the Gulf and Red Sea region could increase export costs. For companies supplying medicines under long-term tender contracts, where pricing is typically fixed, even moderate increases in freight costs may affect profitability.

Air Cargo and Aviation Route Risks

Air cargo plays an important role in the pharmaceutical supply chain, especially for urgent or specialised shipments. The Middle East functions as a major aviation hub connecting India with Europe and North America.

If airspace disruptions expand across Gulf countries, airlines may need to reroute flights. This could lengthen transit times and raise costs for time-sensitive shipments such as oncology medicines, clinical trial materials and high-value active pharmaceutical ingredients.

Supply Chain Risks for Raw Materials

Beyond exports, the conflict may also influence supply chains for pharmaceutical manufacturing inputs. While India exports large volumes of finished medicines, it continues to import certain intermediates and active pharmaceutical ingredients.

Disruptions to tanker movement through the Strait of Hormuz could affect petrochemical supplies. Higher petrochemical prices may increase the cost of solvents, packaging materials and other chemical inputs used in drug production.

Read More: Titagarh Rail’s Italian Associate Firema Transfers Business Unit for €66.1 Million.

Conclusion

Rising geopolitical tensions in the Middle East introduce several logistical uncertainties for India’s pharmaceutical industry. Shipping route disruptions, higher freight costs and potential supply chain challenges could influence export operations and production inputs. While the sector continues to adapt to changing trade conditions, the evolving situation highlights the importance of resilient logistics networks and diversified supply chains.

Disclaimer: This blog has been written exclusively for educational purposes. The securities mentioned are only examples and not recommendations. This does not constitute a personal recommendation or investment advice. It does not aim to influence any individual or entity to make investment decisions. Recipients should conduct their own research and assessments to form an independent opinion about investment decisions. 

Investments in the securities market are subject to market risks. Read all related documents carefully before investing.